Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials

BACKGROUND: Cholinesterase inhibitors and memantine have been approved for management of Alzheimer’s disease (AD), but there has been no consensus about the choice of various types and doses of drugs at different stages. Hence, we compared and ranked the efficacy and tolerability of these available...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Kai-Xin, Tan, Meng-Shan, Tan, Chen-Chen, Cao, Xi-Peng, Hou, Xiao-He, Guo, Qi-Hao, Tan, Lan, Mok, Vincent, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309083/
https://www.ncbi.nlm.nih.gov/pubmed/30591071
http://dx.doi.org/10.1186/s13195-018-0457-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309083/
https://www.ncbi.nlm.nih.gov/pubmed/30591071
http://dx.doi.org/10.1186/s13195-018-0457-9

Ejemplares similares